<!DOCTYPE html>
<html>

	<head>
	 <meta charset="UTF-8">
	 <meta name="description" content="This is an awesome website!">
	<title>Bill's BioPharma Watch</title>
<link href="stylesheet.css" rel="stylesheet">
	</head>
	<body style="background-color:tan" >
<h1>Bill's BioPharma Watch</h1>
<ul>
	<li><a class="nav-item" href="index.html" >Home</a></li>
	<li><a class="nav-item" href="About.html" >About</a></li>
	<li><a class="nav-item" href="WatchList.html">WatchList</a></li>
	<li><div class="dropdown">
			<button class="dropbtn"style="background-color:tan;">2020</button>
				<div class="dropdown-content">
				<!--<a href="September.html" >September</a> !-->
				<a href="October.html" >October</a>
				<a href="November.html" >November</a>
				<a href="December.html" >December</a>

			</div>
		</div>
	<li><div class="dropdown">
	<button class="dropbtn"style="background-color:tan;">2021</button>
		<div class="dropdown-content">
			<a href="Janurary.html" >Janurary</a>
			<a href="February.html" >February</a>
			<a href="March.html" >March</a></li>
			</div>
		</div>
	<div class="tradingview-widget-container">
	  <div class="tradingview-widget-container__widget"></div>
	  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com" rel="noopener" target="_blank"></a></div>
	  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-ticker-tape.js" async>
	  {
	  "symbols": [
	    {
	      "description": "",
	      "proName": "NASDAQ:GILD"
	    },
	    {
	      "description": "",
	      "proName": "HRMY"
	    },
	    {
	      "description": "",
	      "proName": "ETON"
	    },
	    {
	      "description": "",
	      "proName": "AQST"
	    },
	    {
	      "description": "",
	      "proName": "BCRX"
	    },
	    {
	      "description": "",
	      "proName": "ZSAN"
	    },
	    {
	      "description": "",
	      "proName": "KMPH"
	    },
	    {
	      "description": "",
	      "proName": "ADMP"
	    },
	    {
	      "description": "",
	      "proName": "FBIO"
	    },
	    {
	      "description": "",
	      "proName": "LQDA"
	    },
	    {
	      "description": "",
	      "proName": "MNK"
	    },
	    {
	      "description": "",
	      "proName": "NYSE:PFE"
	    },
	    {
	      "description": "",
	      "proName": "SPPI"
	    }
	  ],
	  "colorTheme": "light",
	  "isTransparent": true,
	  "displayMode": "adaptive",
	  "locale": "en"

	}
	  </script>
	</div>
<p align="center">
		<img width="500" src="November.png" />

<h2 align="center">ADAMIS PHARMACEUTICALS CORP</h2>
<Center>
<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/ADMP/" rel="noopener" target="_blank"></a></div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "ADMP",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>
</center>
<!-- TradingView Widget END -->

<p><b>A</b>damis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States.
   The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including
   anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma;
   Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides
   corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and
   certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California. <i>Source Fidelity.com</i>
</p>
<p>
<center>
	<div class="pdufa-container">
    <div class="pdufa-container"><b>ADMP PDUFA Dates</b></div>
    <div class="pdufa-container">ZIMHI (naloxone HCI Injection) - November 15th</div>
		</div>


  <span class="research-container"><h3>Links</h3>
	  <span><a class="research-container" href="http://www.adamispharmaceuticals.com/" target="_blank" >Company Website</a></span>
	  <span><a class="research-container" href="https://finance.yahoo.com/quote/ADMP?p=ADMP" target="_blank">Yahoo Fiance</a></span>
	  <span><a class="research-container" href="https://stocktwits.com/symbol/ADMP" target="_blank">StockTwits</a></span>
	  <span><a class="research-container" href="https://www.tradingview.com/symbols/NASDAQ-ADMP/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></span>
	  <span><a class="research-container" href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></span>
	</center>
</span>
<p><hr></p>

<h2 align="center">LIQUIDIA TECHNOLOGIES INC</h2>

<center>
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/ADMP/" rel="noopener" target="_blank"></a></div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "ADMP",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>
</center>

<p><b>L</b>iquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of novel products which utilize PRINT technology to
	transform the lives of patients. Its lead product candidate is LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials for the treatment of pulmonary
	arterial hypertension. The company also develops LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. It has collaboration agreement with the
	University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina. <i>Source Fidelity.com</i>
</p>


<center>
  <div class="pdufa-container">
    <div class="pdufa-container"><b>LQDA PDUFA Dates</b></div>
    <div class="pdufa-container">LIQ861 - INSPIRE - November 24th</div>
	</div>



  <span class="research-container"><h3>Links</h3>
	  <span><a class="research-container" href="https://liquidia.com/" target="_blank" >Company Website</a></span>
	  <span><a class="research-container" href="https://finance.yahoo.com/quote/LQDA?p=LQDA" target="_blank">Yahoo Fiance</a></span>
	  <span><a class="research-container" href="https://stocktwits.com/symbol/LQDA" target="_blank">StockTwits</a></span>
	  <span><a class="research-container" href="https://www.tradingview.com/symbols/NASDAQ-LQDA/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></span>
	  <span><a class="research-container" href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></span>
	</span>
</center>
	</body>
</html>
